As psoriasis is treated as a generalized inflammation disorder with a higher cardiovascular risk, evaluating serum zyxin levels may offer insight into shared pathogenic mechanisms and their potential role as biomarkers of systemic involvement. This evidence concerns the gene ZYX and psoriasis.